Status:

WITHDRAWN

Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts

Lead Sponsor:

University of Michigan

Conditions:

Breast Cancer

Breast Abnormalities

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine if breast imaging with ultrasound can be improved by using 1) a ultrasound attachment with two transducers and 2) a contrast agent. These changes might allow ...

Detailed Description

The purpose of this study is to determine if performing ultrasound with an attachment made up of two transducers (rather than just a single transducer) will provide more information about the blood ve...

Eligibility Criteria

Inclusion

  • Female subjects who have breast masses and scheduled for core biopsy.

Exclusion

  • Pregnant or lactating females.
  • Females who have heart problems or sensitivity to contrast agents.
  • Females who have had previous surgery for breast cancer.

Key Trial Info

Start Date :

April 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00722683

Start Date

April 1 2001

End Date

December 1 2010

Last Update

October 18 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan Health System

Ann Arbor, Michigan, United States, 48109